← Research library

[Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophrenia].

Observational study · 2018

What was studied
43 men aged 20–55 with schizophrenia and asthenic symptoms
Main finding
Adjunctive Bestim was associated with reduced asthenic symptom scores during complex psychiatric treatment.

Affective-asthenic subgroup · 32.5%

Reported findings and study design

43 men aged 20–55 with schizophrenia and asthenia; clinical assessments before treatment and 5/30 days afterward.

Population or model 43 men aged 20–55 with schizophrenia and asthenic symptoms

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Affective-asthenic subgroup32.5%
Asthenic-negative subgroup67.5%
Later symptom regression in asthenic-negative subgroupMore marked in the authors’ comparisonp<0.001

The percentages describe symptom categories, not responder rates.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • An untreated concurrent control and random allocation are not established by the abstract; improvement cannot be attributed to Bestim alone.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Source details

Original journal report

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Abstract reviewed

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Yakimets AV, Zozulya SA, Oleichik IV, Klyushnik TP. [Dynamics of clinical and biological indices of the asthenic symptom-complex during immunotropic therapy of patients with schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 29652309

Study source ↗ · DOI 10.17116/jnevro20181183170-76 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards